News

US health reform bill will hinder introduction of generic forms of biological drugs, critics say

BMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b4088 (Published 06 October 2009) Cite this as: BMJ 2009;339:b4088
  1. Janice Hopkins Tanne
  1. 1New York

    Medical students and consumer groups in the United States have objected to parts of the proposed healthcare reform bills, which they say will make it more difficult to introduce cheap generic forms of biological drugs (drugs derived biologically rather than chemically).

    The American Medical Students Association and the consumer groups Universities Allied for Essential Medicines, Essential Action, and Knowledge Ecology International say that provisions in several Senate and House of Representatives healthcare reform bills will block the introduction of most generic biologicals. Improving the proposed bills could save $71bn (£45bn; €49bn) …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe